W
COLL icon

WealthCollab’s Collegium Pharmaceutical COLL Stock Holding History

WealthCollab’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Sell
57
-29
-34% -$991 ﹤0.01% 862
2026
Q1 		$2.85K Hold
86
– – ﹤0.01% 798
2025
Q4 		$3.98K Hold
86
– – ﹤0.01% 776
2025
Q3 		$3.01K Hold
86
– – ﹤0.01% 771
2025
Q2 		$2.54K Sell
86
-347
-80% -$9.9K ﹤0.01% 784
2025
Q1 		$12.9K Sell
433
-98
-18% -$3K 0.01% 409
2024
Q4 		$15.2K Buy
531
+253
+91% +$8.37K 0.01% 372
2024
Q3 		$10.7K Buy
278
+71
+34% +$2.53K 0.01% 445
2024
Q2 		$6.67K Buy
+207
New +$7.18K ﹤0.01% 511

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

WealthCollab's COLL Position: Q2 2026 in Review

WealthCollab reduced its Collegium Pharmaceutical (COLL) stake by 34% in Q2 2026, selling an estimated $991 and leaving 57 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

WealthCollab first reported a position in COLL in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.2K in Q4 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • WealthCollab held 57 shares of Collegium Pharmaceutical worth $2.06K as of Q2 2026.
  • WealthCollab sold 29 Collegium Pharmaceutical shares in Q2 2026, an estimated $991.
  • Collegium Pharmaceutical made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #862 holding.
  • WealthCollab first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
  • WealthCollab's Collegium Pharmaceutical position peaked at $15.2K in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.